-
The pharmaceutical sector ushered in a good layout opportunity, and the industry continues to focus on these segments
Time of Update: 2021-10-20
At the same time, the three quarterly reports are about to usher in a concentrated disclosure period, and it is recommended to pay attention to the targets of the rapid growth of CXO industry performance .
-
$200 million transaction!
Time of Update: 2021-10-20
In the United States, Sutro is exploring STRO-001 as a treatment for advanced patients with multiple myeloma (MM) and non-Hodgkin's lymphoma (NHL), including diffuse large B-cell lymphoma, mantle cell lymphoma, and follicles Lymphoma .
-
Within a day, there were also changes in the executives of many pharmaceutical companies
Time of Update: 2021-10-20
On October 14, Warner Pharmaceuticals issued an announcement stating that Li Mengchun had applied for resignation as director, deputy general manager, and secretary of the board of directors due to job changes .
-
Chain giants have a new acquisition!
Time of Update: 2021-10-20
According to relevant data, the number of Yifeng stores in Central and South China has increased from 559 in 2015 to 2,858 by the end of 2020, an increase of more than 2,000 in five years .
-
4 billion anti-tumor injections!
Time of Update: 2021-10-20
On October 15, the official website of the State Food and Drug Administration showed that the supplementary application of Pemetrexed Disodium for Injection by Shandong New Times Pharmaceutical was approved .
-
The State Food and Drug Administration revised the instructions for 10 dosage forms including antiviral syrup and capsules
Time of Update: 2021-10-20
4. [Precautions] item should be changed:"Patients with severe chronic diseases such as hypertension, heart disease, liver disease, diabetes, kidney disease should be taken under the guidance of a physician .
-
Announcement of Public Bidding for Oral Cone Beam CT Procurement Project of Qingdao Shanda Qilu Hospital
Time of Update: 2021-10-20
Announcement of Public Bidding for Oral Cone Beam CT Procurement Project of Qingdao Shanda Qilu Hospital Project Overview: Potential bidders of the oral cone beam CT procurement project bidding project should purchase this project on the National Public Resource Trading Platform (Qingdao City, Shandong Province) Qingdao City Public Resource Trading Electronic Service System (http://ggzy.
-
The National Health Commission issued a blockbuster medical reform document to deepen the reform of the medical and health system
Time of Update: 2021-10-20
On October 15, the National Health Commission issued the "Implementation Opinions of the State Council Leading Group on Deepening the Reform of the Medical and Health System on Deepening the Promotio
-
Heyu Medicine, a leader in the development of new oncology drugs in China, successfully listed on the Hong Kong main board, Qiming Ventures welcomes its 10th IPO this year
Time of Update: 2021-10-20
Shanghai, October 15, 2021/PRNewswire/ - On October 13, Beijing time, Qiming Venture Capital, China's leading tumor drug research and development leader, and Yu Medicine successfully listed on the main board of the Hong Kong Stock Exchange .
-
What kind of sparks will the 5G + traditional Chinese medicine industry collide with?
Time of Update: 2021-10-20
It is reported that in Pan'an County, Jinhua City, Zhejiang Province, known as the "Hometown of Chinese Medicinal Materials", digital intelligence is empowering the Chinese medicine industry here .
-
Recently, a number of pharmaceutical companies announced the cancellation of subsidiaries
Time of Update: 2021-10-20
Coincidentally, Jinling Pharmaceutical also recently issued an announcement stating that the company reviewed and approved the "Proposal on Canceling Branches" at the eleventh meeting of the Eighth Board of Directors held on September 28 .
-
China's biotechnology industry is active in IPO financing, with a total of 4.6 billion US dollars in financing during the year
Time of Update: 2021-10-20
According to Refinitiv's data, there will be 19 Chinese biotech companies IPOs in 2020, mainly listed in Hong Kong, which have raised a total of US$5.
-
With the acceleration of the innovation and transformation of the pharmaceutical industry, pharmaceutical companies are expanding production
Time of Update: 2021-10-20
It is worth noting that in order to meet the growing demand for clinical services and improve production capacity and service efficiency, many pharmaceutical companies are currently expanding production by using new technologies and new projects to prepare for improving market competitiveness .
-
As the innovation of the traditional Chinese medicine industry continues to accelerate, the era of innovative drugs is about to come
Time of Update: 2021-10-20
Regarding the continuous increase in the number of clinical applications and listings of new Chinese medicines, the industry believes that it is the result of China's traditional Chinese medicine industry vigorously promoting innovative development .
-
Roche, Sanofi, Bojian and other pharmaceutical companies announced the latest clinical data of MS drugs
Time of Update: 2021-10-20
Data from the Phase IIb long-term extension study for relapsing multiple sclerosis showed that after 48 weeks of treatment, Tolebrutinib reduced the activity of multiple sclerosis .
-
Preview of the third quarterly report of the API industry
Time of Update: 2021-10-20
Regarding the reasons for the changes in performance, Huahai Pharmaceutical said that during the reporting period, the company’s net profit attributable to shareholders of listed companies after deducting non-recurring gains and losses fell sharply year-on-year, mainly due to the general decline in raw material drug product prices, the decline in the US dollar exchange rate, and product sales.
-
With the rapid growth of the children's drug market, the research and development of specialty drugs is facing challenges
Time of Update: 2021-10-20
The industry believes that with the liberalization of China's "three-child" policy, the potential of the new population will continue to be released, and children's drug companies will also have more development opportunities .
-
Chinese medicine companies take the road of high-quality development, and smart pharmaceutical equipment will become an important promoter
Time of Update: 2021-10-20
It is reported that more and more traditional Chinese medicine companies have begun to abandon the traditional backward pharmaceutical technology and equipment, and then use professional intelligent, automated, and digital equipment to promote the development of the industry with higher quality .
-
As pharmaceutical company executives continue to change, high-level talents become the focus of pharmaceutical companies' competition
Time of Update: 2021-10-20
Among them, especially the turnover of core executives of pharmaceutical innovation companies will become more frequent, and the competition for high-level talents by pharmaceutical companies will also intensify .
-
Pioneer of Innovative Tumor Immune AI Drugs-Xunbaihui Biotechnology completed Series B financing, Coatue led the investment
Time of Update: 2021-10-20
Xunbaihui is an innovative drug company with unique technologies in the discovery of new targets for tumor immunotherapy and the development of antibody drugs .
Xunbaihui uses high-throughput functional genomics and artificial intelligence technology to find new targets for tumor immune drugs and develop effective antibody drugs .
